In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances

@article{Vandeputte2020InVF,
  title={In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances},
  author={Marthe Vandeputte and Annelies Cannaert and C. Stove},
  journal={Archives of Toxicology},
  year={2020},
  pages={1 - 12}
}
The landscape of new psychoactive substances (NPS) is constantly evolving, with new compounds entering the illicit drug market at a continuous pace. Of these, opioid NPS form a threat given their high potency and prevalence. Whereas previously, the use of fentanyl and fentanyl derivatives was the main point of attention, legislations have reacted accordingly, which may have been a driving force towards the (ab)use of alternative µ-opioid receptor (MOR) agonists. In contrast to fentanyl… Expand
6 Citations
First report on brorphine: the next opioid on the deadly new psychoactive substances' horizon?
  • 2

References

SHOWING 1-10 OF 98 REFERENCES
Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological Issue.
  • 24
The search for the “next” euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning
  • 17
  • Highly Influential
  • PDF
First report on brorphine: the next opioid on the deadly new psychoactive substances' horizon?
  • 2
Novel synthetic opioids: A review of the literature
  • 6
Activation of μ opioid receptors by MT-45 and its fluorinated derivatives.
  • 1
Misuse of Novel Synthetic Opioids: A Deadly New Trend
  • 110
  • PDF
...
1
2
3
4
5
...